Supplier profile
Vivanta Generics s.r.o.
Every public-sector award we hold for this supplier, across Germany and Spain, from 22 Mar 2023 to 25 Jul 2026.
Awards won
50
all time
Attributed value
€283k
46 shared, unvalued
Buyers
13
public bodies
Active
2023–2026
first to latest award
Awards by year
Who they win from
| Buyer | Awards | Value |
|---|---|---|
| DAK-Gesundheit | 15 | not attributable |
| GWQ ServicePlus AG | 8 | not attributable |
| AOK Baden-Württemberg | 6 | not attributable |
| IKK classic | 6 | €149k |
| Techniker Krankenkasse | 4 | €1 |
| Kaufmännische Krankenkasse - KKH | 2 | not attributable |
| Servicio de Salud - Servicios Centrales | 2 | €134k |
| Teilnehmende Gesundheitseinrichtungen der EKK plus GmbH | 2 | €1k |
| BARMER Beschaffung und Vergabe | 1 | not attributable |
| CONSORCI HOSPITAL CLÍNIC DE BARCELONA (HCB) | 1 | not attributable |
What they win
Awards
Showing 1–25 of 50 awards we hold
- Germany – Pharmaceutical products – 35. Generikaausschreibung (2/3er) - Bekanntmachung vergebener Aufträge ↗GWQ ServicePlus AGshared awardawarded 25 Jul 2026
- Germany – Pharmaceutical products – 35. Generikaausschreibung (2/3er) - Bekanntmachung vergebener Aufträge ↗GWQ ServicePlus AGshared awardawarded 25 Jul 2026
- Aciclovir (CRE) ↗GWQ ServicePlus AGshared awardawarded 24 Jul 2026
- Aciclovir (CRE) ↗GWQ ServicePlus AGshared awardawarded 24 Jul 2026
- Germany – Pharmaceutical products – Arzneimittelausschreibung 2026_vergebene Aufträge ↗IKK classicshared awardawarded 9 Jul 2026
- Germany – Pharmaceutical products – Arzneimittelausschreibung 2026_vergebene Aufträge ↗IKK classicshared awardawarded 9 Jul 2026
- 001 | Acetylsalicylsäure magensaftresistente Tabletten u.w. [3] [H] ↗IKK classicshared awardawarded 8 Jul 2026
- 001 | Acetylsalicylsäure magensaftresistente Tabletten u.w. [3] [H] ↗IKK classicshared awardawarded 8 Jul 2026
- Atorvastatin ↗AOK Baden-Württembergshared awardawarded 15 Apr 2026
- Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Rivaroxaban, ATC B01AF01 für die Zeit 01.04.2026 - 30.06.2026 ↗DAK-Gesundheitshared awardawarded 2 Apr 2026
- Germany – Pharmaceutical products – Abschluss von Rabattverträgen gemäß § 130a Abs. 8 SGB V für Arzneimittel im generischen Markt ↗AOK Baden-Württembergshared awardawarded 1 Apr 2026
- Germany – Pharmaceutical products – Generikaausschreibung ↗BARMER Beschaffung und Vergabeshared awardawarded 27 Mar 2026
- Germany – Pharmaceutical products – 34. Generikaausschreibung (2/3er) - Auftragsbekanntmachung ↗GWQ ServicePlus AGshared awardawarded 20 Jan 2026
- Acarbose ↗GWQ ServicePlus AGshared awardawarded 20 Jan 2026
- Germany – Pharmaceutical products – Ausschreibung über Arzneimittel- Rahmenrabattverträge nach §130a Absatz 8 SGB V ↗Kaufmännische Krankenkasse - KKHshared awardawarded 19 Dec 2025
- DAK-G/KKH Wirkstoff Amifampridin ATC WHO: N07XX05 ↗Kaufmännische Krankenkasse - KKHshared awardawarded 19 Dec 2025
- Lacosamid ↗Teilnehmende Gesundheitseinrichtungen der EKK plus GmbH€1kawarded 9 Dec 2025
- Germany – Pharmaceutical products – Eisencarboxymaltose und Lacosamid ↗Teilnehmende Gesundheitseinrichtungen der EKK plus GmbHshared awardawarded 28 Nov 2025
- Amantadin FTA - TK, hkk, HEK (ATC-Code: N04BB01) ↗Techniker Krankenkasseshared awardawarded 6 Oct 2025
- Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Teriflunomid, ATC L04AK02 für die Zeit 01.10.2025 - 31.12.2025 (zzgl. Verlängerungsoption 1x12 Monate) ↗DAK-Gesundheitshared awardawarded 2 Oct 2025
- Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Ticagrelor, ATC B01AC24 für die Zeit 01.06.2025 - 31.05.2027 (zzgl. Verlängerungsoption 1x12 Monate) ↗DAK-Gesundheitshared awardawarded 2 Oct 2025
- Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Teriflunomid, ATC L04AK02 für die Zeit 01.10.2025 - 31.12.2025 (zzgl. Verlängerungsoption 1x12 Monate) ↗DAK-Gesundheitshared awardawarded 1 Oct 2025
- Germany – Pharmaceutical products – Ersatzkassen-Generika Nr. 25 (Bekanntmachung vergebener Aufträge) ↗Techniker Krankenkasseshared awardawarded 20 Sept 2025
- Spain – Antineoplastic agents – suministro de medicamentos de uso humano respetuoso con el medio ambiente para el tratamiento de la fibrosis pulmonar idiopática ↗Dirección General de Gestión Económica, Contratación e Infraestructuras de la Conselleria de Sanidadshared awardawarded 26 Aug 2025
- Germany – Pharmaceutical products – Abschluss von Rabattverträgen gemäß § 130a Abs. 8 SGB V für Arzneimittel im generischen Markt ↗AOK Baden-Württembergshared awardawarded 5 Aug 2025
Bidding against them?
Get new tenders in their space in a daily digest, scored against your own capability — plus the full notice behind each of these awards, with the documents and contacts it published.
Start 7-day free trialHow this profile is built
Awards are collected from official public procurement notices and deduplicated so one procurement counts once. Supplier names are grouped across their published spellings: case and punctuation are ignored, and “Ltd” is treated as optional because buyers routinely leave it off. Everything else that marks a different organisation is kept — an LLP, a plc, a CIC and a Teoranta are separate businesses from a Ltd of the same name, as are a parent and a named subsidiary, and none of them are merged here. Where another entry differs from this one only by legal form or a bracketed qualifier it is listed above as possibly the same organisation — a hint for the reader, never a merge: figures are per legal entity and never combined. Value is attributed only where the notice is explicit: the supplier's own itemised amount, or the whole value where they were the sole named supplier. Awards naming several suppliers without a published split are counted and marked shared, never valued, and a framework ceiling is never treated as money any one appointed supplier won. Sterling and euro are never added together. The linked source notice is authoritative.
Company pages are for organisations. If this page profiles you as an individual — a sole trader or an individual contractor — you can ask for it to be withheld: see how.